- active not recruitingPHASE3
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Emicizumab in Participants From Birth to 12 Months of Age With Hemophilia A Without Inhibitors
This study is looking at a medicine called emicizumab for babies up to 12 months old with severe haemophilia A. It aims to see how well it works, if it's safe, and how the body handles it, to help prevent bleeding episodes.
United States · Australia · Austria - recruitingPHASE4
Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
This study looks at how well a medicine called Nuwiq works to prevent bleeding during surgery in people with severe haemophilia A who are already taking another medicine called emicizumab. It's for males aged 12 and over undergoing major operations.
United States · Croatia · Finland - active not recruitingPHASE4
A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis
This study looks at how a medicine called emicizumab affects the overall health, activity levels, and joints of people with moderate or severe haemophilia A. It's for those already receiving another treatment and planning to switch to emicizumab.
United States · Brazil · Canada